MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Pancreas, Pancreatic
HUTCHMED Limited (NASDAQ: HCM)*
Organization & Developments: HUTCHMED
Parents
HUTCHMED Limited (NASDAQ: HCM)*
Children
*HUTCHMED is a commercial-stage, biopharmaceutical company committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.
2022: HUTCHMED (HCM) Investor Presentation - Slideshow_ seekingalpha.com
2025: With $608M divestment, Hutchmed continues to focus on ADC development
Jumps
Finance & Acquisitions: HUTCHMED
Key People: HUTCHMED